Σύγκριση μεθόδων

	Ερωτηματολόγιο Επιπτώσεων Ινομυαλγίας	ΕΟΚΕ ΠΟΙΟΤΗΤΑ ΖΩΗΣ-C30
Πεδίο	Εκβάσεις Υγείας	Εκβάσεις Υγείας
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1991	1993
Δημιουργός	Cynthia S. Burckhardt et al.	Nico Aaronson et al.
Τύπος	Self-report symptom and functional impairment questionnaire	Self-report quality of life questionnaire
Θεμελιώδης πηγή	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Εναλλακτικές ονομασίες	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Συναφείς	4	5
Σύνοψη	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.